Cardiac Troponin Market Report 2026

Cardiac Troponin Market Overview

• Cardiac Troponin market size has reached to $4.24 billion in 2025 • Expected to grow to $6.92 billion in 2030 at a compound annual growth rate (CAGR) of 10.3% • Growth Driver: Rising Heart Disease Prevalence To Fuel Cardiac Troponin Market Growth • Market Trend: Advanced Cardiac Quality Control For Enhanced Troponin Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cardiac Troponin Market?

Cardiac troponin refers to a group of proteins found in heart muscle (myocardium) that help regulate heart contractions. Troponins are part of the muscle fiber proteins that control the interaction between actin and myosin, which are essential for muscle contraction. It acts as a biomarkers which is used to diagnose heart injury, especially heart attacks. The main types of cardiac troponin include troponin I and troponin T. Troponin I is a protein found in heart muscle cells that helps regulate muscle contractions, and elevated levels of Troponin I in the blood can indicate heart injury or stress, making it essential for accurate cardiac diagnostics. The locations of testing include laboratory settings and point-of-care (PoC) testing for applications such as acute coronary syndrome, myocardial infraction, congestive heart failure, and others. The end users include hospitals, diagnostic centers, homecare settings, and others.

What Is The Cardiac Troponin Market Growth Forecast?

The cardiac troponin market size is expected to see rapid growth in the next few years. It will grow to $6.92 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing demand for rapid cardiac diagnostics, rising adoption of decentralized testing solutions, expansion of home-based cardiac monitoring, growing use of ai-supported diagnostic interpretation, increasing focus on early intervention strategies. Major trends in the forecast period include increasing adoption of high-sensitivity troponin assays, rising use of point-of-care cardiac testing, growing integration of automated laboratory diagnostics, expansion of rapid rule-in and rule-out protocols, enhanced focus on early cardiac injury detection.

Global Cardiac Troponin Market Segmentation

1) By Type: Troponin I, Troponin T 2) By Location Of Testing: Laboratory Setting, Point Of Care (Poc) Testing 3) By Application: Acute Coronary Syndrome, Myocardial Infraction 4) By End User: Hospitals, Diagnostic Centers Subsegments: 1) By Troponin I: Conventional Cardiac Troponin I (cTnI), High-Sensitivity Cardiac Troponin I (hs-cTnI) 2) By Troponin T: Conventional Cardiac Troponin T (cTnT), High-Sensitivity Cardiac Troponin T (hs-cTnT)

What Is The Driver Of The Cardiac Troponin Market?

The increasing prevalence of heart-related conditions is expected to propel the growth of the cardiac troponin market going forward. Heart-related conditions encompass a range of cardiovascular diseases, including coronary artery disease, heart failure, arrhythmias, and congenital heart defects, affecting the structure and function of the heart. The increasing prevalence of heart-related conditions is driven by factors such as aging populations, sedentary lifestyles, poor dietary habits, and rising rates of obesity and hypertension. Cardiac troponin is crucial in diagnosing heart-related conditions by serving as a highly sensitive biomarker for detecting heart muscle damage, particularly in cases of heart attacks and other cardiac events. For instance, October 2024, according to the Centers for Disease Control and Prevention, a US-based federal agency, in 2023, 919,032 people died from cardiovascular disease. That's the equivalent of 1 in every 3 deaths. Therefore, the increasing prevalence of heart-related conditions will drive the growth of the cardiac troponin industry.

Key Players In The Global Cardiac Troponin Market

Major companies operating in the cardiac troponin market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings (Labcorp), bioMérieux SA, Beckman Coulter Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Radiometer Medical ApS, Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Meso Scale Diagnostics LLC., Singulex Inc., Diazyme Laboratories Inc., Response Biomedical Corporation, Eurolyser Diagnostica GmbH, LifeSign LLC

Global Cardiac Troponin Market Trends and Insights

Major companies operating in the cardiac troponin market are focusing on developing new technology, such as human serum-based quality control, to ensure accurate and reliable high-sensitivity troponin testing by providing multi-analyte controls. Human serum-based quality control in cardiac troponin testing ensures test accuracy and reliability by using human serum with known troponin concentrations to verify the assay's performance. For instance, in May 2023, Bio-Rad Laboratories, Inc., a US-based biotechnology research company, introduced Cardiac Advance, a four-level, multi-analyte quality control specifically designed for high-sensitivity troponin testing. These liquid, human-serum-based controls are offered in InteliQ 3-mL tubes, Liquichek 3-mL standard, and 2.5-mL compact vials. The controls feature 10 cardiac analytes, including troponin, CK-MB, BNP/proBNP, and myoglobin, and are compatible with Siemens and Roche testing platforms. The products are available in the U.S., Europe, and selected Asian markets.

What Are Latest Mergers And Acquisitions In The Cardiac Troponin Market?

In January 2025, bioMérieux, a France-based provider of in vitro diagnostics and immunoassay solutions, acquired SpinChip Diagnostics ASA foran undisclosed amount. With this acquisition, bioMérieux aims to accelerate the commercialization of SpinChip’s point-of-care immunoassay platform and strengthen its presence in rapid diagnostics, especially for cardiac care and acute-care biomarkers. SpinChip Diagnostics ASA is a Norway-based healthcare company developing a microfluidic, cartridge-based point-of-care diagnostics platform capable of delivering high-sensitivity cardiac troponin I and other immunoassays from a small blood sample in minutes.

Regional Outlook

North America was the largest region in the cardiac troponin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cardiac Troponin Market?

The cardiac troponin market consists of sales of diagnostic assays, test kits, point-of-care testing devices, and high-sensitivity troponin tests. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cardiac Troponin Market Report 2026?

The cardiac troponin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac troponin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.